Waiting Is Not Compounding

1. Why an earnings beat can still send a stock to a decade low

After the market closed on October 1, Nike released its fiscal 2027 first-quarter results.

Start with the good news. Earnings per share were $0.48, above the market expectation of $0.44. Gross margin reached 42.8%, an increase of 60 basis points from a year earlier. On their own, those figures look like a familiar story of improving profitability and disciplined operations.

Now consider the share price. After the results, the stock fell roughly 8% to 10% in premarket trading, reaching its lowest levels in more than a decade. The reported year-to-date decline was about 44% to 45%, and the five-year decline exceeded 76%. These figures refer to the company release and English-language market reports published on October 1 and 2, rather than current prices.

Good-looking results, a bad share-price reaction. Many individual investors instinctively conclude that the market has lost its mind. My first reaction is different: they are looking backward, while the market is pricing what comes next.

A stock’s value reflects discounted future free cash flows. Quarterly results describe what has already happened. The lines that move the price most sharply often concern the future:

• Nike expected fiscal 2027 revenue to decline by a high-single-digit percentage, compared with an earlier analyst expectation of roughly 2%.
• Guidance for adjusted earnings per share was $1.15 to $1.35, against market expectations around $1.65 to $1.69. The midpoint was roughly a quarter lower.
• The decline in earnings before interest and taxes, or EBIT, was expected to exceed the decline in revenue.

The $0.04 quarterly earnings beat matters little beside that change in the full-year outlook. A quarter’s profit is one drop; a repricing of the future is the sea around it.

I do not want this essay to stop at cataloging Nike’s problems. The question is what the market is pricing.

My answer is the time a turnaround will require, and where capital should be allocated while that time passes.

2. A good company does not automatically make a good investment

Consider a question that runs against intuition: if a company might become exceptional again in five years, should you continue holding it today? The instinctive answer is yes, in the name of long-term investing. My answer is: not necessarily.

Many investors reduce a long-term approach to holding something for a long time. That misses its central purpose.

The point is to keep capital allocated over time to places where it can continue to compound.

Holding describes behavior; compounding supplies the standard. At its heart lies the simplest, most frequently neglected idea in economics: opportunity cost. The relevant cost of keeping a stock is not merely what you once paid for it. It includes the return the capital could earn elsewhere. Asking whether Nike can become great again concerns the quality of the company. Asking whether holding Nike from today is the best available use of this capital concerns the quality of the investment.

Those questions can have different answers. You may correctly anticipate an eventual recovery and still make a poor investment by waiting too long for it.

Investors can find once-great companies especially difficult to leave. A poor company has few admirers; its decline carries little emotional weight. A former champion has a reputation, a story, your attachment, and a stubborn reference point. Nike’s earlier peak was around $175, while the price discussed in this essay was roughly $32. Returning from $32 to $175 requires a gain of about 447%. After a decline of more than 80%, the price must rise more than fivefold to recover.

Someone anchored to the peak may think that such a low price is an opportunity too good to miss. But a lower price alone is insufficient. What matters is price alongside evidence of a turn in the business. Without that evidence, apparent cheapness may simply mark another point on the way down.

The expensive mistake may be taking too long to admit that the original judgment could have been wrong.

3. An improving margin can coexist with a weakening brand

Return to the attractive headline: gross margin increased by 60 basis points. Consider it alongside revenue falling about 4% and an outlook in which EBIT declines faster than revenue. What does that combination tell us?

A brand’s most valuable asset often sits in consumers’ minds, rather than on its balance sheet. A successful product, a compelling collaboration, or a moment that makes young people want to wear the brand can build momentum for the next period of growth. That asset can compound. It can also compound in reverse: what once resembled a solid mountain can become an avalanche.

When revenue contracts while margins improve, there are at least two possible interpretations:

• A healthy one: the company has removed inefficient business and retained a more profitable core. It becomes smaller but better.
• An unhealthy one: promotional spending, distribution, and marketing are cut to improve the current income statement, at the expense of future brand strength.

One is pruning; the other is harvesting. Looking only at revenue and margins, the two may appear similar. Expense composition, product performance, and subsequent revenue must distinguish them. In Nike’s actual quarter, the company attributed the margin improvement mainly to lower warehousing and logistics costs, while demand-creation expense rose 5%. An improvement in gross margin therefore does not, on its own, establish that Nike is cutting brand investment.

Operating leverage adds another consideration. A business carries relatively inflexible costs in research, stores, organization, and brand marketing. Rising revenue spreads those costs over more sales, allowing profit to grow faster. Falling revenue can put the same mechanism into reverse. Nike’s outlook for EBIT to fall faster than sales describes that pressure.

My concern is what attractive current figures might conceal about the direction of future compounding.

The clearest warning in this quarter came from Greater China, where sales fell 26% on a currency-neutral basis. In the same release, North America grew 2%, Nike Direct fell 8%, wholesale declined 1%, and Converse declined 28%.

For a brand, a 26% decline in a major region is difficult to dismiss as routine fluctuation. I cannot conclude that an avalanche is inevitable, but I see a possible early warning. Weakening consumer appeal in a key market can interact with inventory, discounts, competing brands, and consumer perceptions. Those effects may take longer than a quarter to work through.

4. The difficult arithmetic of Pace

Nike’s response is Pace, a transformation of its operating model: modernizing the supply chain, establishing a campus in India, moving from four geographic divisions to three, streamlining the organization, and beginning workforce changes in 2027. The company expected $2.5 billion in cumulative savings through fiscal 2031 and about $1 billion in pretax restructuring charges over the same period. That amount is not an immediate cash payment: about $300 million was expected to be recognized in fiscal 2027, in addition to about $300 million in severance costs already recognized in fiscal 2026.

I do not dispute the need for these changes. Reshaping costs and simplifying the organization can be sound management. As an investor, however, I have to ask a less comfortable question: does the arithmetic support the case?

Unpack the savings first. The $2.5 billion is cumulative through fiscal 2031, a simple average of roughly $500 million a year. According to Reuters’ October 2 report, most of the savings would not be realized until fiscal 2029 and 2030. Restructuring charges also span several periods. Recognizing an expense, paying cash, and realizing savings are different events whose timing should not be treated as interchangeable.

Now consider the other side. The following is a hypothetical calculation to illustrate scale, rather than a company forecast:

• Assume annual revenue of roughly $45 billion, using quarterly revenue of $11.21 billion multiplied by four as a rough estimate.
• Assume an 8% revenue decline, within the high-single-digit range. That would remove about $3.6 billion in annual revenue.
• Apply the quarter’s 42.8% gross margin, and the corresponding loss of annual gross profit is roughly $1.5 billion.

In that scenario, $1.5 billion of lost gross profit is considerably larger than $500 million of average savings. Fixed costs may add pressure if they cannot adjust quickly as sales fall. But the $500 million is only a simple annual average of the cumulative savings target, not Nike’s actual saving in each year. Comparing it with a hypothetical gross-profit loss illustrates magnitude; it cannot replace a period-by-period cash-flow calculation.

If restructuring cash payments precede the savings, the timing would become less favorable. Assessing how much less favorable requires the actual schedule of payments and savings. All else equal, an equal amount of cash arriving later has a lower present value than one arriving sooner.

The central point remains: cutting costs may help a business survive, but it cannot, by itself, make consumers want the brand again. That requires renewed strength in products, culture, and distribution: a turn in revenue, rather than an attractive EBIT presentation alone.

5. Take the counterarguments seriously, then define the conditions

You may reasonably ask what the other side of the argument looks like. I take those objections seriously.

First: Jefferies maintained a Buy rating, although its target had been cut from $75 to $60.

According to October 2 reporting on the Jefferies note, the analyst continued to recognize improvements in North America and performance products, while acknowledging pressure in Greater China, Jordan, and Sportswear. A $60 target was still substantially above the roughly $32 price discussed here, but an analyst target is a judgment, not a promised return. Another constructive argument is that November’s investor day and subsequent guidance could clarify the turnaround. The possibility that current expectations already absorb the bad news deserves testing; a new CFO alone does not establish that guidance has deliberately been set low to create later upside surprises.

Second: North America grew 2%.

That suggests the brand had not collapsed in its largest mature market, and that its core products retained appeal. It is a real positive that should not be ignored.

Third: short positions were crowded.

In its September 29, 2026 report, S3 Partners put shares sold short at more than 87 million, with its short-interest measure rising from below 3% to above 7%. Those are the provider’s figures at that date, rather than live data. A crowded short position can become fuel for a rebound if better-than-expected news triggers covering.

This is where reflexivity enters the picture. A share price can affect fundamentals as well as reflect them. A falling price may weaken equity incentives, make financing or acquisitions more expensive, and erode partners’ confidence, adding pressure to operations. A positive surprise may help restore confidence. Crowded shorts contain both information about sentiment and the potential for a sharp reversal.

My purpose is to give a long-term holding an evidence framework: under what conditions does keeping it remain the best use of capital?

• First, revenue stabilizes before we declare success on profit. Watch whether sales declines narrow, especially across several quarters in Greater China, rather than relying on EBIT alone.
• Second, the source of margin improvement can be verified. Does it reflect product mix and pricing power, or contraction in promotions and distribution? The first can be healthy; the second may spend future strength.
• Third, November’s investor day provides a testable route to recovery: dates and measures, including the timing of savings and the limits of restructuring charges, rather than slogans.
• Fourth, evidence supports the rebalancing of distribution. With Nike Direct down 8% and wholesale down 1%, the chosen direction must ultimately earn its case in the data.

The more these conditions are met, the stronger the case for continuing to hold. The fewer that are met, the more the position resembles an emotional option on the Nike you remember.

This is not personal investment advice or a prediction of Nike’s share price. An evidence framework gives you a standard written before new information arrives, rather than an emotional explanation assembled afterward.

6. Your own version of Nike

Now shift the focus from Nike to yourself. Its story offers a useful mirror for employees and entrepreneurs, because you have a personal version of the same asset.

Your career, skills, professional reputation, and relationships can compound. The judgment you have developed over ten years, and what colleagues believe about your work, form a valuable personal brand. It can accumulate strength, or lose it.

What does harvesting that asset look like?

• Earning a high salary from skills developed a decade ago, while your current income statement still looks strong.
• Repeating comfortable work efficiently, posting good annual results, but never extending what you are capable of doing.
• Treating your reputation as something to cash in whenever a short-term benefit appears.

These choices can produce a high apparent margin because little is being reinvested. But eventually the revenue side responds: the industry changes, technology changes, and so does the value of what you offer.

AI brings this pressure into sharper view. A skill that once supported someone for twenty years may now have a much shorter useful life.

Reallocating human capital becomes increasingly necessary. That means:

• Devoting time to capabilities that can keep compounding: judgment, integration across fields, effective collaboration with AI, and trust that has been earned.
• Avoiding continued investment in depreciating skills merely because they are familiar.

This returns us to two abilities a long-term approach requires: the ability to continue, and the ability to stop. Most people train only the first, treating persistence as virtue and stopping as failure. But sunk costs should not determine the future. Opportunity cost and the prospects for compounding should.

Taking the long term seriously means sustaining productive compounding while ending allocations that no longer support it.

A checklist for yourself

Here is a framework you can apply to investments, careers, and businesses. Ask yourself every six months:

1. If I were starting from zero today, would I choose this allocation again? If not, why am I keeping it?
2. Where does my apparent profit come from: new compounding, or consumption of assets built in the past?
3. Is my revenue base expanding or contracting? Look beyond comforting numbers to the source of growth.
4. Is there a Greater China in my own life: an ability or field showing a warning on the scale of a 26% decline, while I reassure myself with other measures?
5. Have I written an evidence framework for continuing? Are the conditions for staying and reallocating explicit?
6. Am I waiting for a reversal, or working to create a turn? Waiting alone is not a strategy; action is.

Nike may become desirable again, or it may not. Time and execution will answer that question about the company. Your question is where to put the next unit of capital, the next hour, and the next year.

Do not keep harvesting your own brand until there is nothing left to grow.

Source note: Company data come from Nike’s announcements; market prices, expectations, and analyst views refer to reports from October 1–2, 2026. Short-position figures come from S3 Partners’ September 29 report. The gross-profit calculation in section four is illustrative, not a company forecast. This essay expresses a personal view and is not investment advice.